Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Naohide Tanaka is active.

Publication


Featured researches published by Naohide Tanaka.


Heart and Vessels | 2005

Improvement of arterial stiffness by the antioxidant and anti-inflammatory effects of short-term statin therapy in patients with hypercholesterolemia.

Takashi Matsuo; Kazunori Iwade; Naomi Hirata; Michio Yamashita; Haruhiko Ikegami; Naohide Tanaka; Masahiko Aosaki; Hiroshi Kasanuki

The preventive effect of statins on coronary events is not only associated with the cholesterol-lowering effect of these drugs, but also various direct effects on the vascular wall, which include improvement of endothelial function, antioxidant activity, and anti-inflammatory activity. We investigated whether short-term statin therapy could improve arterial stiffness and assessed its mechanism of action in patients with hypercholesterolemia. We assessed arterial stiffness in 10 patients (mean age: 62.9 ± 9.0 years) with hypercholesterolemia (total cholesterol ≥220 mg/dl). The patients were treated with cerivastatin (0.15 mg/day) for 4 weeks. Before and after 4 weeks of treatment, we determined arterial stiffness from brachial-ankle pulse wave velocity and the ankle-brachial blood pressure index (ABI) using a FORM apparatus (Colin, Komaki, Japan). We also measured the blood levels of high-sensitivity C-reactive protein (hsCRP) and malondialdehyde low-density lipoprotein (MDA-LDL) as markers of inflammation and oxidation, respectively. After statin therapy, both the right and left abPWV were significantly decreased from 1544.6 ± 157.1 to 1349.0 ± 223.9 cm/s and from 1592.1 ± 164.8 to 1424.8 ± 245.2 cm/s, respectively (P < 0.05). However, the ABI was unchanged after 4 weeks of cerivastatin therapy. MDA-LDL decreased significantly (from 161.2 ± 42.4 to 119.4 ± 33.5 U/l, P < 0.05) and hsCRP also decreased. Total cholesterol and LDL-cholesterol decreased, while triglycerides and high-density lipoprotein-cholesterol were unchanged. Blood pressure was not significantly altered from the baseline value by statin therapy. These results suggest that the preventive effect of statins on coronary events is partly associated with the various actions of these drugs on the vascular wall, and that statins are not only cholesterol-lowering agents but also antiatherosclerotic agents.


International Journal of Cardiology | 1996

Comparison between Japan and North America in the post-hospital course after recovery from an acute coronary event

Yasuyuki Nakamura; Chuichi Kawai; Arthur J. Moss; Richard F. Raubertas; Mary W. Brown; Masahiko Kinoshita; Shigetake Sasayama; Hiroshi Nonogi; Teruo Omae; Shunichi Tamaki; Masatoshi Fujita; Naohide Tanaka; Saichi Hosoda; Hiroshi Inoue; Tsuneaki Sugimoto; Hiroyuki Iinuma; Kazuzou Kato; Nagara Tamaki; Nariaki Sugiura

We compared the post-hospital prognosis after an acute coronary event (acute myocardial infarction and unstable angina) in 106 patients in Japan vs. 789 patients in North America who were prospectively enrolled in the Multicenter Study of Myocardial Ischemia and were followed-up for an average of 26 months per patients. Risk factors more frequent in Japan were older age, males and smoking at enrollment, but the rest of many risk factors were similar. After adjusting for differences in clinical and medication variables, Cox analyses indicated patients in North America had a significantly greater risk of experiencing a primary end-point (cardiac death, non-fatal myocardial infarction or unstable angina) than patients in Japan (hazard ratio [North America:Japan] = 3.1, P = 0.003). There was a non-significant trend in the restricted end-points (cardiac death or non-fatal myocardial infarction) with North America having more frequent events than Japan (hazard ratio = 2.2, P = 0.12). The long-term outcome after recovery from an acute coronary event is more favorable in Japan than in North America, mostly due to a reduction in subsequent hospitalization for unstable angina. The reason for these findings cannot be explained by differences in the measured risk factors or medications.


Catheterization and Cardiovascular Interventions | 2005

Coronary angioplasty in a patient with a prior Bentall procedure.

Takahiro Uchida; Fujio Tatsumi; Naohide Tanaka

We reported a case of percutaneous coronary intervention in a patient with a prior Bentall procedure. We observed a neointimal layer with intracoronary ultrasound during a successful intervention procedure through a composite graft 11 years after the Bentall operation.© 2005 Wiley‐Liss, Inc.


International Journal of Cardiology | 1999

Subdivided left atrium mimicking a cardiac tumor

Kazuhiro Shimaya; Akira Kurihashi; Naohide Tanaka; Masafumi Higashidate

We describe a 25-year-old man with a subdivided left atrium. The lesion was misdiagnosed preoperatively as a cardiac tumor because echocardiographic and magnetic resonance imaging revealed a solid mass arising from the posterior wall of the left atrium. Cardiac surgery revealed a small accessory chamber draining the two left pulmonary veins. No membranous structure was evident between the chamber and the left atrium. The solid mass identified noninvasively was a hypertrophic muscle which formed a wall of the accessory chamber.


Kidney International Reports | 2018

Contrast-Induced Nephropathy and Oxygen Pretreatment in Patients With Impaired Renal Function

Haruki Sekiguchi; Yoichi Ajiro; Yoshie Uchida; Kentaro Jujo; Kazunori Iwade; Naohide Tanaka; Ken Shimamoto; Yukio Tsurumi; Masatoshi Kawana; Nobuhisa Hagiwara

Introduction Contrast-induced nephropathy is a complication following coronary angiography and percutaneous coronary intervention. Because contrast-induced nephropathy is a predictor of long-term mortality in patients with ischemic heart disease undergoing percutaneous coronary intervention, preventive strategies are required. We assessed the effects of periprocedural oxygenation on contrast-induced nephropathy among patients with pre-existing renal dysfunction. Methods A total of 200 consecutive patients with impaired renal function (estimated glomerular filtration < 60 ml/min per 1.73 m2) undergoing elective cardiovascular angiography were randomly assigned to an oxygenation treatment (n = 100) or control group (n = 100). In oxygenation treatment, pure oxygen (2 L/min) was administered for 10 minutes before exposure to contrast medium. The primary endpoint was the incidence of contrast-induced nephropathy, defined as a ≥ 25% increase in serum creatinine levels from baseline within 48 hours of exposure. Results In the oxygenation treatment group, partial pressure of arterial oxygen was higher (135 ± 25 mm Hg vs. 84 ± 10 mm Hg, P < 0.001); contrast-induced nephropathy incidence was lower (1% vs. 8%, odds ratio [OR] = 0.12, 95% confidence interval [CI] = 0.01–0.95, P = 0.02); and partial pressure of arterial carbon dioxide and bicarbonate base lactate levels were similar compared with those in the control group. Upon univariate analysis, excess and absence of oxygenation treatment (OR = 9.18, CI = 1.13–74.86, P = 0.03) and anemia (OR = 4.30, CI = 1.04–17.78, P = 0.04) were shown to be associated with contrast-induced nephropathy incidence. Conclusion Oxygenation, a simple, nonpharmacological strategy, may be beneficial when using contrast media in patients with impaired renal function from noninvasive angiography to emergency catheterization.


Journal of the American College of Cardiology | 2013

Oxygen pre-conditioning prevents contrast-induced nephropathy (OPtion CIN Study).

Haruki Sekiguchi; Yoichi Ajiro; Yoshie Uchida; Issei Ishida; Hisao Otsuki; Hidetoshi Hattori; Hiroyuki Arashi; Yasunori Kobayashi; Kentaro Jujo; Junichi Yamaguchi; Masaaki; Kazunori Iwade; Naohide Tanaka; Ken Shimamoto; Yukio Tsurumi; Masatoshi Kawana; Nobuhisa Hagiwara


Global heart | 2014

PM171 Undesirable effect on lipoprotein profile by cardiovascular surgery

Haruki Sekiguchi; Hideki Ohno; Yoichi Ajiro; Fujio Tatsumi; Kazunori Iwade; Naohide Tanaka; Ken Shimamoto; Masatoshi Kawana


Circulation | 2014

Abstract 16549: Prevention of Contrast-Induced Nephropathy by Oxygen Preconditioning in Patients With Impaired Renal Function

Haruki Sekiguchi; Yoichi Ajiro; Yoshie Uchida; Kazunori Iwade; Naohide Tanaka; Ken Shimamoto; Yukio Tsurumi; Masatoshi Kawana; Nobuhisa Hagiwara


Circulation | 2012

Abstract 12235: Oxygenation Prevents Contrast-induced Nephropathy via Nitric Oxide Induction

Haruki Sekiguchi; Yoichi Ajiro; Yoshie Uchida; Issei Ishida; Hisao Otsuki; Hidetoshi Hattori; Hiroyuki Arashi; Yasunori Kobayashi; Kentaro Jujo; Jyunichi Yamaguchi; Fumiaki Mori; Masaaki; Michio Asahi; Kazunori Iwade; Naohide Tanaka; Ken Shimamoto; Yukio Tsurumi; Masatoshi Kawana; Nobuhisa Hagiwara


Circulation | 2011

Abstract 13249: Oxygen Preconditioning Prevents Contrast-Induced Nephropathy after Coronary Angiography in Patient of Ischemic Heart Disease

Haruki Sekiguchi; Issei Ishida; Yoshie Uchida; Hisao Otsuki; Hidetoshi Hattori; Hiroyuki Arashi; Yasunori Kobayashi; Youichi Ajiro; Kentaro Jujo; Jyunichi Yamaguchi; Kazunori Iwade; Naohide Tanaka; Masatoshi Kawana; Nobuhisa Hagiwara

Collaboration


Dive into the Naohide Tanaka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tetsuya Sumiyoshi

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge